Embecta
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New Jersey, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
300 Kimball Dr Ste 300, Parsippany, New ...Phone Number
(862) 401-0000Website
www.embecta.comRevenue
$1 BillionStock Symbol
EMBCIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
1
1
About Embecta
Embecta is a company that specializes in the manufacturing of medical equipment that is used to help treat diabetes. The company is based in Franklin Lakes, New Jersey.Explore more
Embecta Org Chart
JM
President & Chief Legal Officer, Pharma Servi...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Embecta your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Embecta, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Embecta has recently received funding, and reach out quickly before it becomes old news!
Click to see if Embecta had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Embecta
Product Launch: Get notified when Embecta launches new products
Funding: Get notified immidiatlly once Embecta has new funding data
Earning: See what the market has to say on Embecta recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Embecta is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Embecta as Masked Content
Find 3 more new buyers
Compare Similar Companies to Embecta
Compare insights from companies similar to Embecta, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Embecta is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Embecta is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Embecta.
Embecta Tech Stack
A closer look at the technologies used by Embecta
Most Recent Scoops
Product Launch
Embecta has launched its B2B co-packaged pen needles alongside generic GLP-1 therapies in Canada, Brazil, and South Africa, following an initial launch in India, and expects to launch a pen needle small pack format in the US in the coming months to support patients using Zepbound, which was recently made available in a pen injector format.
Product Launch, Pharmaceuticals
Earnings
Embecta has reported total revenue of approximately $272 million for Q3 of fiscal 2026, reflecting a year-over-year decrease of 8.1% on an as-reported basis and a decline of 8.9% on an adjusted constant currency basis. On a sequential basis, revenue increased approximately $50 million compared to Q2, driven by improved performance in the US and international segments, as well as an initial contribution from the Owen Mumford acquisition.
Earnings, Acquisitions, Finance
Earnings
Embecta has reported US revenue of approximately $121 million for Q3 of fiscal 2026, reflecting a year-over-year decline of 24.6% on both a reported and adjusted constant currency basis, while increasing approximately $25 million sequentially compared to Q2, driven by a normalization in distributor order timing and a modest contribution from the Owen Mumford acquisition.
Earnings, Acquisitions, Finance
Project
Embecta has completed its brand transition in key European, Asian, and Latin American markets, with more than 90% of revenue now represented by products commercially launched and shipped under the Embecta label, and remains on track to substantially complete the global brand transition by the end of calendar year 2026.
Branding
Person-Based
Board of Directors
Embecta News & Media
embecta to Participate in Investor Events
In September, embecta will participate in the Wells Fargo 2026 Healthcare Conference and the J.P. Morgan 4th Annual Nashville Healthcare Conference 2026.EMBC Stock News: Embecta Sued for Securities Fraud over Alleged Misrepresentations and Corresponding 57% Stock Drop
A securities fraud class action lawsuit has been filed on behalf of Embecta investors after its stock plummeted over 57% because Embecta allegedly misled investors regarding the strength of its insulin pen needle product category. NEW YORK, Aug. 18, 2026 /PRNewswire/ -- Leading securities...EMBC Deadline: EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit
NEW YORK, Aug. 17, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November 25, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 17, 2026 lead plaintiff deadline....Bronstein, Gewirtz & Grossman LLC Urges Embecta Corp. Investors to Act: Class Action Filed Alleging Investor Harm
New class action for Embecta (EMBC) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 8/17/2026
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Embecta
Sign Up For FreeTo access detailed company insights
Embecta is a company that specializes in the manufacturing of medical equipment that is used to help treat diabetes. The company is based in Franklin Lakes, New Jersey.... Read More
